Trials / Completed
CompletedNCT03451994
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
Retrospective Analysis of Volatile Organic Compounds in Alveolar Breath as Biomarkers of Idiopathic Malodor
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 23 (actual)
- Sponsor
- Mebo Research, Inc. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this secondary analysis is to identify breath signatures associated with idiopathic malodor conditions.
Detailed description
Individuals with metabolic disorders may sporadically produce malodors despite good hygiene. Analysis of volatile organic compounds (VOCs) helps to gain insights into medical conditions arising due to metabolic dysfunction as different metabolic pathways emit and or consume various VOCs. These VOCs can be detected via the exhaled breath collected and analyzed with a portable breath collection apparatus. VOC profiles will be compared with self-reported symptoms and other observations of participating subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Breath test | Breath samples taken from all participants, analyzed with gas chromatography mass spectrometry (GC/MS), no treatment given. |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2013-12-31
- Completion
- 2020-10-11
- First posted
- 2018-03-02
- Last updated
- 2020-10-14
Locations
2 sites across 2 countries: United States, United Kingdom
Source: ClinicalTrials.gov record NCT03451994. Inclusion in this directory is not an endorsement.